Sponsored: The Evolving Role of Stem Cell Transplant in Older AML Patients

Experts discuss the phase III SIERRA trial, which recently demonstrated durable complete responses in patients with acute myeloid leukemia<br /> &nbsp;

Case 1: Primary Induction Failure (PIF)

Case 2: Early Relapse with Remission <6 months

Disease State of AML

SIERRA Trial Design

Hematopoietic

Hillard M. Lazarus, MD, FACP - Case Western Reserve University

Rajneesh Nath, MD - Banner MD Anderson Cancer Center Clinic

Alexander E. Perl, MD, MS - Hospital of the University of Pennsylvania